First Trust Capital Management L.P. Forma Therapeutics Holdings, Inc. Transaction History

First Trust Capital Management L.P.

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2022 Nov 14, 2022	BUY	$7.12 - $20.24 $7.33 Million - $20.8 Million	1,029,333 New	1,029,333 $20.5 Million

26.5K

Ticker FMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,860,400
Market Cap $958M
Description
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...

Get notified when there are updates to the investment portfolio of First Trust Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on First Trust Capital Management L.P. with notifications on news.